ERBB3 and malignant colon neoplasm: In order to evaluate the involvement of HER3 in the responsiveness of colon cancer cells to chemotherapies, we analyzed three patient-derived colon cancer cell lines (Pt-1, Pt-2, Pt-3) and the established colon cancer cell line HT29.